Biodesix, Inc.
BDSX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $71,323 | $49,087 | $38,212 | $54,506 |
| % Growth | 45.3% | 28.5% | -29.9% | – |
| Cost of Goods Sold | $15,573 | $13,010 | $14,154 | $30,518 |
| Gross Profit | $55,750 | $36,077 | $24,058 | $23,988 |
| % Margin | 78.2% | 73.5% | 63% | 44% |
| R&D Expenses | $9,559 | $9,988 | $13,102 | $12,789 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $80,451 | $67,387 | $61,462 | $50,517 |
| Sales & Mktg Exp. | $0 | $0 | $61,462 | $50,517 |
| Other Operating Expenses | $238 | $44 | $81 | $1,622 |
| Operating Expenses | $90,248 | $77,419 | $74,645 | $64,928 |
| Operating Income | -$34,498 | -$41,342 | -$50,587 | -$40,940 |
| % Margin | -48.4% | -84.2% | -132.4% | -75.1% |
| Other Income/Exp. Net | -$8,433 | -$10,804 | -$14,860 | -$2,219 |
| Pre-Tax Income | -$42,931 | -$52,146 | -$65,447 | -$43,159 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$42,931 | -$52,146 | -$65,447 | -$43,159 |
| % Margin | -60.2% | -106.2% | -171.3% | -79.2% |
| EPS | -6.6 | -12.8 | -31 | -31.6 |
| % Growth | 48.4% | 58.7% | 1.9% | – |
| EPS Diluted | -6.6 | -12.8 | -31 | -31.6 |
| Weighted Avg Shares Out | 6,484 | 4,106 | 2,105 | 1,368 |
| Weighted Avg Shares Out Dil | 6,484 | 4,106 | 2,105 | 1,368 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $8,258 | $9,536 | $8,072 | $4,508 |
| Depreciation & Amortization | $5,456 | $5,507 | $5,844 | $3,178 |
| EBITDA | -$29,217 | -$37,103 | -$51,531 | -$35,473 |
| % Margin | -41% | -75.6% | -134.9% | -65.1% |